Oncosec Medical (ONCS) – FDA
-
Oncosec Medical (ONCS) Announces Type C Meeting with FDA
-
Oncosec Medical (ONCS) Reports Strong Early Data of TAVO-EP with nivolumab
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ONCS Stock Lookup